SCHEMBL5089124

SCHEMBL5089124

N#Cc1ccc(O)c(-c2cc(Cl)cc(Cl)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.50
KDM1A O60341 2/20 0.50
TMPRSS4 Q9NRS4 2/20 0.43
KDM4C Q9H3R0 1/20 0.42
P2RX1 P51575 1/20 0.40
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
PGGT1B P53609 1/20 0.40
CYP19A1 P11511 1/20 0.40
MMP3 P08254 1/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
GRM5 P41594 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5093159 0.85 ALOX5 (0.50) MAOAKDM1ATMPRSS4P2RX1FNTA
SCHEMBL11615171 0.80 KDM1A (0.53) MAOAKDM1ATMPRSS4KDM4CMMP3
SCHEMBL5091255 0.80 MAOA (0.51) MAOAKDM1ATMPRSS4KDM4CFNTA
SCHEMBL5088969 0.79 KDM1A (0.51) MAOAKDM1AKDM4CCYP19A1MMP3
SCHEMBL18587832 0.78 MAOA (0.56) MAOAKDM1AKDM4CCYP19A1PIM1
SCHEMBL6201606 0.77 XDH (0.46) ACLYRXRARXRBRXRG
SCHEMBL5098823 0.76 KDM1A (0.51) MAOAKDM1AKDM4CFNTAFNTB
SCHEMBL1424066 0.75 MAOA (0.54) MAOAKDM1AKDM4CCYP19A1MMP3
SCHEMBL2111898 0.75 PTGDR2 (0.56) MAOAKDM1ATMPRSS4P2RX1CNR1
SCHEMBL28221213 0.74 HPGD (0.42) MAOAKDM1ATMPRSS4KDM4CP2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7323570-B2 Farnesyltransferase inhibitors ABBOTT LABORATORIES (US) 2008-01-29 US disclosed
US-7211595-B2 Farnesyltransferase inhibitors ABBOTT LABORATORIES (US) 2007-05-01 US disclosed
US-20060264476-A1 Farnesyltransferase Inhibitors ABBVIE INC. 2006-11-23 US disclosed
EP-1339695-B1 FARNESYLTRANSFERASE INHIBITORS ABBOTT LAB (US) 2006-04-19 EP disclosed
US-20030087940-A1 Farnesyltransferase inhibitors ABBVIE INC. 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264476-A1 Farnesyltransferase Inhibitors FNTB, FNTA, FDPS MAOA 2549/4885KDM1A 4266/4885TMPRSS4 702/4885
US-20030087940-A1 Farnesyltransferase inhibitors FNTB, FNTA, FDPS MAOA 2955/4885KDM1A 3709/4885TMPRSS4 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.